Left Dorsolateral Prefrontal Cortex Glx/tCr Predicts Efficacy of High Frequency 4- to 6-Week rTMS Treatment and Is Associated With Symptom Improvement in Adults With Major Depressive Disorder: Findings From a Pilot Study
Open Access
- 3 December 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 12
Abstract
About 20–40% of estimated 121 million patients with major depressive disorder (MDD) are not adequately responsive to medication treatment. Repetitive transcranial magnetic stimulation (rTMS), a non-invasive, non-convulsive neuromodulation/neurostimulation method, has gained popularity in treatment of MDD. Because of the high cost involved in rTMS therapy, ability to predict the therapy effectiveness is both clinically and cost wise significant. This study seeks an imaging biomarker to predict efficacy of rTMS treatment using a standard high frequency 10-Hz 4- to 6-week protocol in adult population. Given the significance of excitatory and inhibitory neurotransmitters glutamate (Glu) and gamma aminobutyric acid (GABA) in the pathophysiology of MDD, and the involvement of the site of rTMS application, left dorsolateral prefrontal cortex (lDLPFC), in MDD, we explored lDLPFC Glx (Glu + glutamine) and GABA levels, measured by single voxel magnetic resonance spectroscopy (MRS) with total creatine (tCr; sum of creatine and phosphocreatine) as reference, as possible biomarkers of rTMS response prediction. Mescher-Garwood point-resolved spectroscopy (MEGA-PRESS) MRS data from 7 patients (40–74 y) were used in the study; 6 of these patients were scanned before and after 6 weeks of rTMS therapy. Findings from this study show inverse correlation between pretreatment lDLPFC Glx/tCr and (i) posttreatment depression score and (ii) change in depression score, suggesting higher Glx/tCr as a predictor of treatment efficacy. In addition association was observed between changes in depression scores and changes in Glx/tCr ratio. The preliminary findings did not show any such association between GABA/tCr and depression score.Keywords
This publication has 106 references indexed in Scilit:
- An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depressionInternational Journal of Neuropsychopharmacology, 2012
- Functional connectivity in the cognitive control network and the default mode network in late-life depressionJournal of Affective Disorders, 2012
- Towards a glutamate hypothesis of depressionNeuropharmacology, 2012
- Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood DisordersBiological Psychiatry, 2010
- Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depressionMolecular Psychiatry, 2010
- Reduced Density of Calbindin Immunoreactive GABAergic Neurons in the Occipital Cortex in Major Depression: Relevance to Neuroimaging StudiesBiological Psychiatry, 2010
- The functional neuroanatomy of depression: Distinct roles for ventromedial and dorsolateral prefrontal cortexBehavioural Brain Research, 2009
- Effects of age and sex on brain glutamate and other metabolitesMagnetic Resonance Imaging, 2009
- Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depressionBrain Structure and Function, 2008
- An analysis of functional neuroimaging studies of dorsolateral prefrontal cortical activity in depressionPsychiatry Research: Neuroimaging, 2006